Early-stage life sciences companies are increasingly in the spotlight these days, with an uptick in investor interest and M&A activity in the space. In “The Relationship between Funding and Exit Paths”, MABA founder Yaniv Sneor shares some background about our group and discusses potential exit strategies a young life science company may consider and how an exit strategy will, in most cases, determine the funding
By piskov|2024-02-04T18:54:14+00:00February 4th, 2024|Categories: Press news|Comments Off on MABA Founder Yaniv Sneor on TEN Capital Network – The Relationship between Funding and Exit Paths
Mid Atlantic Bio Angels group (MABA), is an angel investor group focused exclusively on new and emerging life science companies.
Membership in MABA is by invitation only, and is extended to active, accredited investors (life science angels) who wish to make investments in life science companies, as well as institutional investors and life science company venture arms wishing to invest alongside the angels.